Category

No image
Inquiry Submitted Successfully

Glipizide

  • Product Name : Glipizide
  • Grade : IP / BP / USP
  • Therapeutic Category : Antidiabetic
  • CAS No : 29094-61-9
  • COA : Available
  • MSDS : Available

Description

Glipizide is an ATP-dependent K+ channels blocker in pancreatic β cells and brain GABA containing neurons resulting in insulin release.

Glipizide is an oral rapid- and short-acting anti-diabetic medication from the sulfonylurea class. It is classified as a second-generation sulfonylurea, which means that it undergoes enterohepatic circulation. Second-generation sulfonylureas are both more potent and have shorter half-lives than the first-generation sulfonylureas.

 

Specification:

 

Tests

Specifications

Results

Appearance

White or almost white crystalline powder

White crystalline powder

Identification

IR: The IR absorption spectrum of sample corresponds to that of reference one

Complies

Loss on drying

Not more than 0.5%

0.1%

Residue on ignition

Not more than 0.2%

0.03%

Related substances

Impurity A

Impurity X3

Unspecified impurity

Total impurities

 

Not more than 0.3%

Not more than 0.15%

Not more than 0.10%

Not more than 0.5%

 

0.10%

0.08%

0.04%

0.26%

Impurity B

Not more than 0.01%

N.D

Assay

98.0%~102.0%

( Calculated on dried basis)

99.4%

Conclusion

Complies with BP

 

 Packaging details:

 

Packaging details:

25kg/drum with double plastic bags inside; packed in a cardboard drum or fiber HDPE drum.

Storage:

Stored in a clean, cool, dry area; keep away from moisture and strong, direct light/heat

Shelf Life:

5 years if sealed and store away from direct sun light.

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

North & South America: USA, Canada, Panama, Trinidad and Tobago, Costa Rica, Puerto Rico, Dominican Republic, Argentina, Guatemala, Guyana, Peru, Bolivia, Venezuela , Brazil, Bahamas, Ecuador, etc .

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.

×